Medicinal plants in cancer patients: Current practices and evaluation data;Les plantes médicinales chez les malades atteints de cancers: Pratiques courantes et éléments de leur évaluation

Bulletin du Cancer

Volumn 100, Issue 5, 2013, Pages 485-495

  Huet, Matthieu ^a,b  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^b Kroaz Ar Gall   (France)

Author keywords

Cancer; Complementary and alternative medicines; Herbal medicine; Medicinal plants; Phytotherapy

Indexed keywords

CANCER PATIENT; HUMAN; MEDICINAL PLANT; REVIEW; RISK BENEFIT ANALYSIS;

EID: 84880235113     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2013.1741     Document Type: Article

References (56)

1. Ernst E, Cassileth BR. The prevalence of complementary/ alternative medicine in cancer: a systematic review. Cancer 1998 ; 83: 777-82.
2. Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004 ; 22: 2489-503.
3. Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005 ; 16: 655-63.
4. Simon L, Prebay D, Beretz A, et al. Médecines complé mentaires et alternatives suivies par les patients cancéreux en France. Bull Cancer 2007 ; 94: 483-8.
5. Träger-Maury S, Tournigand C, Maindrault-Goebel F, et al. Utilisation de médecine complémentaire chez les patients atteints de cancer dans un service de cancérologie français. Bull Cancer 2007 ; 94: 1017-25.
6. Rodrigues M, Wassermann J, Barthélémy P, et al. Utilisation des médecines alternatives et complémentaires par les patients en cancérologie: résultats de l'étude MAC-AERIO. In: Euro cancer 2010 compte rendu du XXIIIe Congrès, 22-23-24 juin 2010, Palais des Congrès, Paris. Montrouge: John Libbey Eurotext, 2010, p. 95-6.
7. Thomas-Schoemann A, Alexandre J, Mongaret C, et al. Prise d'antioxydants et d'autres thérapies complémentaires par les patients sous chimiothérapie antitumorale: étude prospective. Bull Cancer 2011 ; 98: 645-53.
8. Prescrire rédaction. Gingembre et nausées. Prescrire 2008 ; 28: 849-50.
9. Chaiyakunapruk N, Kitikannakorn N, Nathisuwan S, Leeprakobboon K, Leelasettagool C. The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis. Am J Obstet Gynecol 2006 ; 194: 95-9.
10. Pillai AK, Sharma KK, Gupta YK, Bakhshi S. Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy. Pediatr Blood Cancer 2011 ; 56: 234-8.
11. Ryan JL, Heckler CE, Roscoe JA, et al. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer [Internet] 2011 (available from: http://www.ncbi.nlm.nih. gov/pubmed/21818642; cited 2011 Oct 27).
12. Pommier P, Gomez F, Sunyach MP, D'Hombres A, Carrie C, Montbarbon X. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 2004 ; 22: 1447-53.
13. McQuestion M. Evidence-based skin care management in radiation therapy: clinical update. Semin Oncol Nurs 2011 ; 27: e1-17.
14. Abdelmeguid NE, Chmaisse HN, Abou Zeinab NS. Silymarin ameliorates cisplatin-induced hepatotoxicity in rats: histopathological and ultrastructural studies. Pak J Biol Sci 2010 ; 13: 463-79.
15. Rašković A, Stilinović N, Kolarović J, Vasović V, Vukmirovi ć S, Mikov M. The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules 2011 ; 16: 8601-13.
16. Ladas EJ, Kroll DJ, Oberlies NH, et al. A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Cancer 2010 ; 116: 506-13.
17. Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: a review. Nutr J 2002 ; 1: 4.
18. Alkreathy H, Damanhouri ZA, Ahmed N, Slevin M, Ali SS, Osman AMM. Aged garlic extract protects against doxorubicininduced cardiotoxicity in rats. Food Chem Toxicol 2010 ; 48: 951-6.
19. Mukherjee S, Banerjee SK, Maulik M, Dinda AK, Talwar KK, Maulik SK. Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-alpha expression. BMC Pharmacol 2003 ; 3: 16.
20. Goetz P. Le ginseng vertus thérapeutiques d'une plante adaptogène. Paris: Springer, 2009.
21. Qi F, Li A, Inagaki Y, et al. Chinese herbal medicines as adjuvant treatment during chemo-or radio-therapy for cancer. Biosci Trends 2010 ; 4: 297-307.
22. Kim JH, Park CY, Lee SJ. Effects of sun ginseng on subjective quality of life in cancer patients: a double-blind, placebo-controlled pilot trial. J Clin Pharm Ther 2006 ; 31: 331-4.
23. Available from: http://clinicaltrials.gov/show/NCT01375114; cited 2011 Nov 8.
24. Tacyildiz N, Ozyoruk D, Yavuz G, et al. Soy isoflavones ameliorate the adverse effects of chemotherapy in children. Nutr Cancer 2010 ; 62: 1001-5.
25. Ahmad IU, Forman JD, Sarkar FH, et al. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer. Nutr Cancer 2010 ; 62: 996-1000.
26. Sharma P,Wisniewski A, Braga-Basaria M, et al. Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy. J Urol 2009 ; 182: 2265-72.
27. Warnke PH, Sherry E, Russo PAJ, et al. Antibacterial essential oils in malodorous cancer patients: clinical observations in 30 patients. Phytomedicine 2006 ; 13: 463-7.
28. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010 ; 49: 1603-16.
29. Wang J, Yi J. Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther 2008 ; 7: 1875-84.
30. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 2008 ; 100: 773-83.
31. Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev 2007 ; 33: 407-18.
32. Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer 2008 ; 123: 1227-39.
33. Liska D, Lyon M, Jones DS. Detoxification and biotransformational imbalances. Explore (NY) 2006 ; 2: 122-40.
34. Boehm K, Borrelli F, Ernst E, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev 2009 ; 3: CD005004.
35. Kim JY, Kwon O. Garlic intake and cancer risk: an analysis using the Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims. Am J Clin Nutr 2009 ; 89: 257-64.
36. Dong JY, Qin LQ. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 2011 ; 125: 315-23.
37. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008 ; 98: 9-14.
38. Qin LQ, Xu JY,Wang PY, Hoshi K. Soyfood intake in the prevention of breast cancer risk in women: a meta-analysis of observational epidemiological studies. J Nutr Sci Vitaminol 2006 ; 52: 428-36.
39. Zaineddin AK, Vrieling A, Buck K, et al. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status. Int J Cancer 2012 ; 130: 1401-10.
40. Buck K, Vrieling A, Zaineddin AK, et al. Serum enterolactone and prognosis of postmenopausal breast cancer. J Clin Oncol 2011 ; 29: 3730-8.
41. Tanaka S, Haruma K, Yoshihara M, et al. Aged garlic extract has potential suppressive effect on colorectal adenomas in humans. J Nutr 2006 ; 136(3 Suppl.): 821S-6S.
42. Bruneton J. Pharmacognosie: phytochimie, plantes médicinales, 4e éd. Paris: Éditions Tec & Doc, 2009.
43. You W, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006 ; 98: 974-83.
44. Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst [Internet] 2012 (available from: http://www.ncbi.nlm.nih.gov/pubmed/22271764; cited 2012 Feb 7).
45. Shanafelt TD, Call TG, Zent CS, et al. Phase I trial of daily oral polyphenol E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J Clin Oncol 2009 ; 27: 3808-14.
46. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 2006 ; 66: 1234-40.
47. Jatoi A, Ellison N, Burch PA, et al. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 2003 ; 97: 1442-6.
48. Hooper L, Madhavan G, Tice JA, Leinster SJ, Cassidy A. Effects of isoflavones on breast density in pre-and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update 2010 ; 16: 745-60.
49. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril 2004 ; 82: 145-8 (quiz 265).
50. Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008 ; 269: 226-42.
51. Jagetia G, Krishnan SK, Aggarwal BB. Natural agents that can sensitize tumor cells to chemotherapy and radiation therapy [Internet]. In: Bonavida B, ed. Sensitization of cancer cells for chemo/immuno/radio-therapy. Totowa, NJ: Humana Press, 2008, p. 211-40 (available from: http://www.springerlink.com/ content/ j70uq642n4777733/; cited 2011 Nov 28).
52. Seely D, Dugoua JJ, Perri D, Mills E, Koren G. Safety and efficacy of panax ginseng during pregnancy and lactation. Can J Clin Pharmacol 2008 ; 15: e87-94.
53. Rossi I. La parole comme soin: cancer et pluralisme thérapeutique. Anthropol Sante [Internet] 2011 ; 2 (available from: http://anthropologiesante. revues.org/659; cited 2011 Nov 6).
54. Cohen P, Rossi I. Le pluralisme thérapeutique en mouvement. Anthropol Sante [Internet] 2011 (available from: http://anthropologiesante. revues.org/606; cited 2011 Nov 6).
55. Venin P, Taïeb S, Carpentier P. La décision partagée. Rev Prescrire 2002 ; 22: 864-5.
56. Prescrire rédaction. Les patients veulent savoir. Rev Prescrire 2011 ; 31: 937.